182 related articles for article (PubMed ID: 38714239)
1. Evaluation of anti-sickling effects of two varieties of Cajanus cajan (L.) Huth on sickle cell beta thalassemia.
Anorue EC; Joshua PE
J Ethnopharmacol; 2024 Sep; 331():118280. PubMed ID: 38714239
[TBL] [Abstract][Full Text] [Related]
2. Underutilized legumes, Cajanus cajan and Glycine max may bring about antisickling effect in sickle cell disease by modulation of redox homeostasis in sickled erythrocytes and alteration of its functional chemistry.
Elemo GN; Erukainure OL; Okafor JNC; Banerjee P; Preissner R; Nwachukwu Nicholas-Okpara VA; Atolani O; Omowunmi O; Ezeanyanaso CS; Awosika A; Shode F
J Food Biochem; 2022 Sep; 46(9):e14322. PubMed ID: 35894096
[TBL] [Abstract][Full Text] [Related]
3. Potential of Three Ethnomedicinal Plants as Antisickling Agents.
Nurain IO; Bewaji CO; Johnson JS; Davenport RD; Zhang Y
Mol Pharm; 2017 Jan; 14(1):172-182. PubMed ID: 28043127
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of reversal of pre-sickled erythrocytes by the aqueous extract of Cajanus cajan seeds.
Ogoda Onah J; Akubue PI; Okide GB
Phytother Res; 2002 Dec; 16(8):748-50. PubMed ID: 12458479
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of haemoglobin S and membrane stability of sickle erythrocytes.
Mpiana PT; Ngbolua KN; Bokota MT; Kasonga TK; Atibu EK; Tshibangu DS; Mudogo V
Blood Transfus; 2010 Oct; 8(4):248-54. PubMed ID: 20967165
[TBL] [Abstract][Full Text] [Related]
6. Phytomedicines (medicines derived from plants) for sickle cell disease.
Oniyangi O; Cohall DH
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004448. PubMed ID: 29446825
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of the anti-sickling properties of Buchholzia coriacea and Mucuna pruriens seed extracts.
Ikechukwu EL; Okafor PN; Egba SI
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):773-782. PubMed ID: 33025340
[TBL] [Abstract][Full Text] [Related]
8. Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia.
Imaga NA
ScientificWorldJournal; 2013; 2013():269659. PubMed ID: 23476125
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia.
Akinsulie AO; Temiye EO; Akanmu AS; Lesi FE; Whyte CO
J Trop Pediatr; 2005 Aug; 51(4):200-5. PubMed ID: 15917266
[TBL] [Abstract][Full Text] [Related]
10. Phytomedicines (medicines derived from plants) for sickle cell disease.
Oniyangi O; Cohall DH
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD004448. PubMed ID: 32977351
[TBL] [Abstract][Full Text] [Related]
11. Antisickling activity of hydroxybenzoic acids in Cajanus cajan.
Akojie FO; Fung LW
Planta Med; 1992 Aug; 58(4):317-20. PubMed ID: 1438591
[TBL] [Abstract][Full Text] [Related]
12. Cajanus cajan- a source of PPARĪ³ activators leading to anti-inflammatory and cytotoxic effects.
Schuster R; Holzer W; Doerfler H; Weckwerth W; Viernstein H; Okonogi S; Mueller M
Food Funct; 2016 Sep; 7(9):3798-806. PubMed ID: 27603115
[TBL] [Abstract][Full Text] [Related]
13. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
[TBL] [Abstract][Full Text] [Related]
14. Antisickling effect of chrysin is associated with modulation of oxygenated and deoxygenated haemoglobin via alteration of functional chemistry and metabolic pathways of human sickle erythrocytes.
Nwankwo HC; Idowu AA; Muhammad A; Waziri AD; Abubakar YS; Bashir M; Erukainure OL
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S108-S124. PubMed ID: 34151613
[TBL] [Abstract][Full Text] [Related]
15. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin inĀ vivo?
Oder E; Safo MK; Abdulmalik O; Kato GJ
Br J Haematol; 2016 Oct; 175(1):24-30. PubMed ID: 27605087
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of a microbead assay for the easy evaluation of traditional anti-sickling medicines: application to DREPANOSTAT and FACA.
Villaret J; Marti G; Dubois F; Reybier K; Gaudre N; Haddad M; Valentin A
Pharm Biol; 2018 Dec; 56(1):385-392. PubMed ID: 30261794
[TBL] [Abstract][Full Text] [Related]
17. The in vitro antisickling and antioxidant effects of aqueous extracts Zanthoxyllum heitzii on sickle cell disorder.
Pauline N; Cabral BN; Anatole PC; Jocelyne AM; Bruno M; Jeanne NY
BMC Complement Altern Med; 2013 Jul; 13():162. PubMed ID: 23829696
[TBL] [Abstract][Full Text] [Related]
18. Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
Henry ER; Metaferia B; Li Q; Harper J; Best RB; Glass KE; Cellmer T; Dunkelberger EB; Conrey A; Thein SL; Bunn HF; Eaton WA
Blood; 2021 Sep; 138(13):1172-1181. PubMed ID: 34197597
[TBL] [Abstract][Full Text] [Related]
19. Phytomedicines (medicines derived from plants) for sickle cell disease.
Oniyangi O; Cohall DH
Cochrane Database Syst Rev; 2015 Apr; (4):CD004448. PubMed ID: 25844571
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.
Xu GG; Pagare PP; Ghatge MS; Safo RP; Gazi A; Chen Q; David T; Alabbas AB; Musayev FN; Venitz J; Zhang Y; Safo MK; Abdulmalik O
Mol Pharm; 2017 Oct; 14(10):3499-3511. PubMed ID: 28858508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
